New Results
Decreased neutralization of SARS-CoV-2 global variants by therapeutic anti-spike protein monoclonal antibodies
View ORCID ProfileTakuya Tada, View ORCID ProfileBelinda M. Dcosta, Hao Zhou, Ada Vaill, Wes Kazmierski, Nathaniel R. Landau
doi: https://doi.org/10.1101/2021.02.18.431897
Takuya Tada
1Department of Microbiology, NYU Grossman School of Medicine, New York, NY 10016, USA
Belinda M. Dcosta
1Department of Microbiology, NYU Grossman School of Medicine, New York, NY 10016, USA
Hao Zhou
1Department of Microbiology, NYU Grossman School of Medicine, New York, NY 10016, USA
Ada Vaill
2Biohaven Pharmaceuticals, Inc., 215 Church Street, New Haven, CT 06510, USA
Wes Kazmierski
2Biohaven Pharmaceuticals, Inc., 215 Church Street, New Haven, CT 06510, USA
Nathaniel R. Landau
1Department of Microbiology, NYU Grossman School of Medicine, New York, NY 10016, USA

Article usage
Posted February 19, 2021.
Decreased neutralization of SARS-CoV-2 global variants by therapeutic anti-spike protein monoclonal antibodies
Takuya Tada, Belinda M. Dcosta, Hao Zhou, Ada Vaill, Wes Kazmierski, Nathaniel R. Landau
bioRxiv 2021.02.18.431897; doi: https://doi.org/10.1101/2021.02.18.431897
Subject Area
Subject Areas
- Biochemistry (9159)
- Bioengineering (6797)
- Bioinformatics (24054)
- Biophysics (12149)
- Cancer Biology (9564)
- Cell Biology (13819)
- Clinical Trials (138)
- Developmental Biology (7654)
- Ecology (11732)
- Epidemiology (2066)
- Evolutionary Biology (15536)
- Genetics (10664)
- Genomics (14352)
- Immunology (9504)
- Microbiology (22883)
- Molecular Biology (9120)
- Neuroscience (49092)
- Paleontology (357)
- Pathology (1487)
- Pharmacology and Toxicology (2577)
- Physiology (3851)
- Plant Biology (8349)
- Synthetic Biology (2300)
- Systems Biology (6204)
- Zoology (1302)